ATE56206T1 - N-((trimethoxy-2,4,6-benzoyl)-3-propyl>piperidi - derivate, verfahren zu ihrer herstellung und deren anwendung als heilmittel. - Google Patents

N-((trimethoxy-2,4,6-benzoyl)-3-propyl>piperidi - derivate, verfahren zu ihrer herstellung und deren anwendung als heilmittel.

Info

Publication number
ATE56206T1
ATE56206T1 AT87400970T AT87400970T ATE56206T1 AT E56206 T1 ATE56206 T1 AT E56206T1 AT 87400970 T AT87400970 T AT 87400970T AT 87400970 T AT87400970 T AT 87400970T AT E56206 T1 ATE56206 T1 AT E56206T1
Authority
AT
Austria
Prior art keywords
piperidi
trimethoxy
medicines
benzoyl
propyl
Prior art date
Application number
AT87400970T
Other languages
English (en)
Inventor
Louis Lafon
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Application granted granted Critical
Publication of ATE56206T1 publication Critical patent/ATE56206T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT87400970T 1986-04-28 1987-04-27 N-((trimethoxy-2,4,6-benzoyl)-3-propyl>piperidi - derivate, verfahren zu ihrer herstellung und deren anwendung als heilmittel. ATE56206T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8606133A FR2597864B1 (fr) 1986-04-28 1986-04-28 Nouveaux derives de la n-((trimethoxy-2,4,6-benzoyl)-3 propyl) piperidine, leurs procedes de preparation et leur application en therapeutique
EP87400970A EP0244318B1 (de) 1986-04-28 1987-04-27 N-[(Trimethoxy-2,4,6-benzoyl)-3-propyl]piperidin-Derivate, Verfahren zu ihrer Herstellung und deren Anwendung als Heilmittel

Publications (1)

Publication Number Publication Date
ATE56206T1 true ATE56206T1 (de) 1990-09-15

Family

ID=9334690

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87400970T ATE56206T1 (de) 1986-04-28 1987-04-27 N-((trimethoxy-2,4,6-benzoyl)-3-propyl>piperidi - derivate, verfahren zu ihrer herstellung und deren anwendung als heilmittel.

Country Status (9)

Country Link
US (1) US4755522A (de)
EP (1) EP0244318B1 (de)
JP (1) JPS6322070A (de)
AT (1) ATE56206T1 (de)
CA (1) CA1293731C (de)
DE (1) DE3764701D1 (de)
ES (1) ES2036215T3 (de)
FR (1) FR2597864B1 (de)
GR (1) GR3001147T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3913682A1 (de) * 1989-04-26 1990-10-31 Bayer Ag 3-aryl-pyrrolidin-2,4-dione
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
MX2008014450A (es) 2006-05-18 2009-03-09 Mannkind Corp Inhibidores de cinasa intracelular.
ES2601856T3 (es) * 2007-06-08 2017-02-16 Mannkind Corporation Inhibidores de la IRE-1A

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092133B1 (de) * 1970-05-06 1974-03-22 Orsymonde
FR2101045A1 (en) * 1970-08-12 1972-03-31 Penciolelli Madeleine Omega-dialkylamino-1-(2,4,6-trialkoxy phenyl) alkan-1-ones - with vasodilator and spasmolytic activity
FR2504136A1 (fr) * 1981-04-15 1982-10-22 Lafon Labor (2,6-dimethoxy-4-hydroxyphenyl)-(3-piperidinopropyl)-cetone et ses sels d'addition, utilisation en therapeutique et procede de preparation
FR2534912B1 (fr) * 1982-10-26 1985-06-28 Lafon Labor Nouveaux derives de (2,4,6-trimethoxyphenyl) - (3-piperidinopropyl) -cetone, utilisation en therapeutique et procede de preparation

Also Published As

Publication number Publication date
JPS6322070A (ja) 1988-01-29
CA1293731C (en) 1991-12-31
US4755522A (en) 1988-07-05
EP0244318B1 (de) 1990-09-05
ES2036215T3 (es) 1993-05-16
FR2597864A1 (fr) 1987-10-30
GR3001147T3 (en) 1992-06-25
FR2597864B1 (fr) 1990-11-16
EP0244318A1 (de) 1987-11-04
DE3764701D1 (de) 1990-10-11

Similar Documents

Publication Publication Date Title
BR9105062A (pt) Processo de preparacao de compostos
ATE175201T1 (de) Mono-n-substituierte 1,4,7,10- tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
ATE128458T1 (de) Naphtylalkylamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE174920T1 (de) Pyridothiadiazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE66609T1 (de) Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung.
ATE152707T1 (de) Neue naphthalin-amide und sulfonamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE69406853T2 (de) Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
ATE56206T1 (de) N-((trimethoxy-2,4,6-benzoyl)-3-propyl>piperidi - derivate, verfahren zu ihrer herstellung und deren anwendung als heilmittel.
DE59509647D1 (de) Aminosäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE172976T1 (de) 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
PT92540A (pt) Processo para a preparacao de derivados de anfotericina b
ATE70837T1 (de) Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
CA2249756A1 (fr) Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PT84680B (pt) Processo para a preparacao de derivados de 1,5-benzotiazepina e de composicoes farmaceuticas que os contem
DE68911616D1 (de) Piperazin-Derivate und Verfahren zu deren Herstellung.
ATE71101T1 (de) Spiro (4,5> decanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE12643T1 (de) 2-0- und 5-0-substituierte 1.4;3.6-dianhydrohexit-mononitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
ATE123776T1 (de) Aminoalkylchromone, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
DE69300011D1 (de) Diacylglycerol-Nicotinate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
ATE149T1 (de) 2-(n-(2'-chlor-4'-methylthienyl-3')-n-(cyclopropyl- methyl)-amino)-imidazolin-(2), dessen saeureadditionssalze, dieses enthaltende arzneimittel und verfahren zu seiner herstellung.
ATE158576T1 (de) Alpha-aryl-alpha-hydroxy-beta- imidazolinylpropionsäureamide
DE3764330D1 (de) 2,2;6,6-diethylen-3-oxo-17alpha-pregn-4-en-21, 17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharm. praeparate.
ATE80629T1 (de) Beta-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln.
DE69400283T2 (de) (Cyclohexyl)alkenderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
ES2103553T3 (es) Nuevos cicloalquil-(b)-indoles, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee